Latest Alkaloids Stories
SEATTLE, May 12, 2011 /PRNewswire/ -- Cell Therapeutics, Inc.
DALLAS and NEW YORK, May 10, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC.
TooNiceStocks research has found that Talon Therapeutics is poised for major breakthroughs with their patented drug Marqibo. Marqibo is a nanoparticle encapsulated cancer therapeutic.
VIENNA and BETHLEHEM, Pa., April 26, 2011 /PRNewswire/ -- In collaboration with Saladax Biomedical, Inc., the Central European Society for Anticancer Drug Research (CESAR) announced today that enrollment has begun in the CEPAC-TDM trial of paclitaxel therapeutic drug management (TDM) with subsequent pharmacokinetic-guided dose adjustment in patients being treated for advanced non-small cell lung cancer (NSCLC).
SEATTLE, WA, April 4 /PRNewswire-FirstCall/ - Oncothyreon Inc.
CALGARY, March 17 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
SEATTLE, March 1 /PRNewswire-FirstCall/ - Oncothyreon Inc.
SEATTLE, Feb. 23, 2011 /PRNewswire/ -- Cell Therapeutics, Inc.
CALGARY, Feb. 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
HUNTSVILLE, Ala., Feb. 2, 2011 /PRNewswire/ -- EGEN, Inc. today announced that the Food and Drug Administration (FDA) has awarded the company a four-year grant of $1,600,000 to assist in the Phase II clinical development of EGEN-001, the company's lead product.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.